Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXC13
|
ENSG00000123364.3 | homeobox C13 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_54331845_54331996 | HOXC13 | 615 | 0.476448 | 0.59 | 9.2e-02 | Click! |
chr12_54332054_54332205 | HOXC13 | 406 | 0.638874 | 0.38 | 3.1e-01 | Click! |
chr12_54329292_54329443 | HOXC13 | 3168 | 0.112603 | 0.33 | 3.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_54427392_54427581 | 1.43 |
ENSG00000207571 |
. |
248 |
0.73 |
chr4_138452878_138453572 | 1.12 |
PCDH18 |
protocadherin 18 |
340 |
0.94 |
chr9_90812890_90813286 | 1.05 |
ENSG00000252299 |
. |
176096 |
0.03 |
chr3_32010054_32010475 | 1.05 |
OSBPL10 |
oxysterol binding protein-like 10 |
12528 |
0.2 |
chr9_97768076_97768588 | 0.91 |
C9orf3 |
chromosome 9 open reading frame 3 |
1054 |
0.55 |
chr7_15723868_15724269 | 0.84 |
MEOX2 |
mesenchyme homeobox 2 |
2369 |
0.37 |
chr4_138045655_138046009 | 0.82 |
ENSG00000222526 |
. |
103450 |
0.09 |
chr15_49716260_49716444 | 0.81 |
FGF7 |
fibroblast growth factor 7 |
895 |
0.66 |
chr6_161649839_161650239 | 0.77 |
AGPAT4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
45012 |
0.2 |
chr4_114679710_114679861 | 0.77 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
2439 |
0.44 |
chr15_49717369_49717525 | 0.74 |
FGF7 |
fibroblast growth factor 7 |
1990 |
0.39 |
chr11_121800761_121801203 | 0.71 |
ENSG00000252556 |
. |
74081 |
0.11 |
chr4_5709733_5710324 | 0.69 |
EVC2 |
Ellis van Creveld syndrome 2 |
266 |
0.93 |
chr2_97593731_97594362 | 0.69 |
ENSG00000252845 |
. |
28506 |
0.12 |
chr21_38071900_38072434 | 0.68 |
SIM2 |
single-minded family bHLH transcription factor 2 |
176 |
0.94 |
chr12_54367495_54368083 | 0.68 |
HOXC11 |
homeobox C11 |
877 |
0.24 |
chr6_152701966_152702349 | 0.66 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
476 |
0.79 |
chr21_17796711_17796936 | 0.66 |
ENSG00000207638 |
. |
114586 |
0.06 |
chr5_42424322_42424771 | 0.65 |
GHR |
growth hormone receptor |
520 |
0.88 |
chr1_95388573_95389173 | 0.64 |
CNN3 |
calponin 3, acidic |
2464 |
0.27 |
chr15_56207406_56207680 | 0.63 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
309 |
0.92 |
chr3_69494300_69494459 | 0.63 |
FRMD4B |
FERM domain containing 4B |
58949 |
0.16 |
chr18_61555576_61555794 | 0.61 |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
692 |
0.68 |
chr1_8157048_8157215 | 0.60 |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
70763 |
0.1 |
chr4_183066487_183066672 | 0.60 |
AC108142.1 |
|
177 |
0.77 |
chr2_153252119_153252297 | 0.59 |
FMNL2 |
formin-like 2 |
60457 |
0.15 |
chr15_30112674_30113382 | 0.59 |
TJP1 |
tight junction protein 1 |
723 |
0.64 |
chr6_121869435_121869626 | 0.58 |
ENSG00000201379 |
. |
5758 |
0.25 |
chr3_132316198_132316509 | 0.58 |
ACKR4 |
atypical chemokine receptor 4 |
272 |
0.93 |
chr1_186415843_186415994 | 0.58 |
PDC |
phosducin |
281 |
0.89 |
chr21_32715523_32716836 | 0.58 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
415 |
0.91 |
chr2_61898002_61898506 | 0.57 |
ENSG00000206973 |
. |
65503 |
0.12 |
chr12_84202284_84202435 | 0.57 |
ENSG00000221148 |
. |
374868 |
0.01 |
chr1_226373050_226373207 | 0.57 |
ACBD3 |
acyl-CoA binding domain containing 3 |
1303 |
0.44 |
chr20_57458298_57458576 | 0.57 |
ENSG00000225806 |
. |
5410 |
0.15 |
chr8_70180166_70180390 | 0.57 |
ENSG00000238808 |
. |
157469 |
0.04 |
chr12_50614114_50614771 | 0.55 |
RP3-405J10.4 |
|
1055 |
0.35 |
chr17_58821066_58821723 | 0.55 |
ENSG00000252534 |
. |
5013 |
0.22 |
chr2_177001025_177001411 | 0.55 |
HOXD3 |
homeobox D3 |
467 |
0.41 |
chr2_207077565_207077805 | 0.55 |
GPR1 |
G protein-coupled receptor 1 |
410 |
0.79 |
chr6_19837611_19837907 | 0.55 |
ID4 |
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
142 |
0.95 |
chr1_92329705_92329906 | 0.55 |
TGFBR3 |
transforming growth factor, beta receptor III |
2655 |
0.31 |
chr1_115711115_115711431 | 0.54 |
TSPAN2 |
tetraspanin 2 |
79152 |
0.1 |
chr12_104443529_104443940 | 0.54 |
GLT8D2 |
glycosyltransferase 8 domain containing 2 |
180 |
0.94 |
chr2_151335990_151336454 | 0.53 |
RND3 |
Rho family GTPase 3 |
5674 |
0.35 |
chr16_4000635_4001034 | 0.53 |
RP11-462G12.1 |
|
389 |
0.84 |
chr4_183370400_183371073 | 0.52 |
TENM3 |
teneurin transmembrane protein 3 |
584 |
0.84 |
chr12_91570174_91570436 | 0.52 |
DCN |
decorin |
2024 |
0.44 |
chr4_138531037_138531225 | 0.52 |
PCDH18 |
protocadherin 18 |
77483 |
0.13 |
chr22_36233928_36234199 | 0.52 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
2202 |
0.43 |
chr13_93879365_93880233 | 0.52 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr2_151260036_151260226 | 0.51 |
RND3 |
Rho family GTPase 3 |
81765 |
0.12 |
chr4_157692546_157692809 | 0.51 |
RP11-154F14.2 |
|
69834 |
0.11 |
chr2_177501805_177501995 | 0.51 |
ENSG00000252027 |
. |
27504 |
0.25 |
chr8_116669547_116669770 | 0.51 |
TRPS1 |
trichorhinophalangeal syndrome I |
4247 |
0.37 |
chr7_17030060_17030455 | 0.51 |
AGR3 |
anterior gradient 3 |
108646 |
0.07 |
chr12_54623683_54623971 | 0.51 |
ENSG00000265371 |
. |
1433 |
0.25 |
chr3_55062710_55062861 | 0.50 |
LRTM1 |
leucine-rich repeats and transmembrane domains 1 |
61670 |
0.15 |
chr15_71184312_71185443 | 0.50 |
LRRC49 |
leucine rich repeat containing 49 |
88 |
0.55 |
chr3_183893852_183894003 | 0.50 |
AP2M1 |
adaptor-related protein complex 2, mu 1 subunit |
639 |
0.55 |
chr5_92918344_92919004 | 0.50 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
369 |
0.84 |
chr5_42772787_42772984 | 0.50 |
CCDC152 |
coiled-coil domain containing 152 |
15965 |
0.2 |
chr10_29922441_29923089 | 0.50 |
SVIL |
supervillin |
1136 |
0.54 |
chr15_33130691_33130971 | 0.50 |
FMN1 |
formin 1 |
49624 |
0.13 |
chr14_52122113_52122363 | 0.50 |
FRMD6 |
FERM domain containing 6 |
3540 |
0.25 |
chr3_167811230_167811432 | 0.50 |
GOLIM4 |
golgi integral membrane protein 4 |
1801 |
0.51 |
chr2_138721657_138722065 | 0.49 |
HNMT |
histamine N-methyltransferase |
19 |
0.99 |
chr2_40591741_40591959 | 0.49 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
65570 |
0.13 |
chr9_684288_685148 | 0.48 |
RP11-130C19.3 |
|
837 |
0.67 |
chr3_174157107_174157258 | 0.48 |
NAALADL2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
1595 |
0.57 |
chr12_78333571_78333722 | 0.48 |
NAV3 |
neuron navigator 3 |
26410 |
0.27 |
chr2_235861878_235862318 | 0.48 |
SH3BP4 |
SH3-domain binding protein 4 |
1378 |
0.62 |
chr22_24133174_24133325 | 0.48 |
SMARCB1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
4051 |
0.11 |
chr22_42740354_42740612 | 0.47 |
TCF20 |
transcription factor 20 (AR1) |
861 |
0.66 |
chr11_125923465_125923616 | 0.47 |
CDON |
cell adhesion associated, oncogene regulated |
9166 |
0.21 |
chr2_216297601_216297993 | 0.47 |
FN1 |
fibronectin 1 |
2993 |
0.27 |
chr17_46650833_46651193 | 0.47 |
HOXB3 |
homeobox B3 |
372 |
0.67 |
chr5_98123899_98124050 | 0.46 |
RGMB |
repulsive guidance molecule family member b |
14635 |
0.21 |
chr18_53089837_53090372 | 0.46 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr13_35962874_35963128 | 0.46 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
87831 |
0.09 |
chr10_133793669_133793880 | 0.46 |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
1653 |
0.46 |
chr15_49750562_49750855 | 0.46 |
FGF7 |
fibroblast growth factor 7 |
35251 |
0.19 |
chr10_35098017_35098428 | 0.46 |
PARD3 |
par-3 family cell polarity regulator |
6027 |
0.24 |
chr12_95557800_95557974 | 0.46 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
47138 |
0.13 |
chr7_120954228_120954379 | 0.46 |
WNT16 |
wingless-type MMTV integration site family, member 16 |
11118 |
0.27 |
chr2_33359781_33360142 | 0.45 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
237 |
0.96 |
chr10_97035689_97035840 | 0.45 |
PDLIM1 |
PDZ and LIM domain 1 |
15017 |
0.22 |
chr4_184509430_184509787 | 0.45 |
ENSG00000239116 |
. |
6154 |
0.2 |
chr16_4069505_4069681 | 0.45 |
RP11-462G12.4 |
|
12420 |
0.19 |
chr15_96878987_96879612 | 0.45 |
ENSG00000222651 |
. |
2809 |
0.21 |
chr5_168726900_168727416 | 0.45 |
SLIT3 |
slit homolog 3 (Drosophila) |
555 |
0.83 |
chr1_164531809_164532055 | 0.45 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
110 |
0.98 |
chr2_120064088_120064263 | 0.45 |
STEAP3-AS1 |
STEAP3 antisense RNA 1 |
57528 |
0.1 |
chr9_78871246_78871464 | 0.45 |
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
67800 |
0.13 |
chr7_27192241_27192392 | 0.44 |
HOXA-AS3 |
HOXA cluster antisense RNA 3 |
2645 |
0.09 |
chr11_122050649_122050906 | 0.44 |
ENSG00000207994 |
. |
27761 |
0.16 |
chr7_35460237_35460417 | 0.44 |
TBX20 |
T-box 20 |
166569 |
0.04 |
chr20_17538596_17539086 | 0.44 |
BFSP1 |
beaded filament structural protein 1, filensin |
642 |
0.72 |
chr2_134484670_134484906 | 0.44 |
ENSG00000200708 |
. |
131126 |
0.05 |
chr9_89952337_89952906 | 0.44 |
ENSG00000212421 |
. |
77256 |
0.11 |
chr7_94024612_94024816 | 0.43 |
COL1A2 |
collagen, type I, alpha 2 |
841 |
0.73 |
chr12_54426653_54426823 | 0.43 |
HOXC5 |
homeobox C5 |
101 |
0.88 |
chr1_78961763_78961914 | 0.43 |
PTGFR |
prostaglandin F receptor (FP) |
5081 |
0.31 |
chr7_94026049_94026200 | 0.43 |
COL1A2 |
collagen, type I, alpha 2 |
2251 |
0.42 |
chr6_10441253_10441637 | 0.43 |
ENSG00000263705 |
. |
1495 |
0.38 |
chr18_67714648_67714914 | 0.43 |
RTTN |
rotatin |
26827 |
0.24 |
chr12_58283114_58283371 | 0.43 |
CTDSP2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
42720 |
0.08 |
chr8_58715313_58715521 | 0.43 |
FAM110B |
family with sequence similarity 110, member B |
191696 |
0.03 |
chr17_48295929_48296104 | 0.43 |
COL1A1 |
collagen, type I, alpha 1 |
17023 |
0.11 |
chr2_203882992_203883167 | 0.42 |
NBEAL1 |
neurobeachin-like 1 |
3477 |
0.29 |
chr1_72809770_72809921 | 0.42 |
NEGR1 |
neuronal growth regulator 1 |
61428 |
0.16 |
chr9_138361112_138361415 | 0.42 |
PPP1R26-AS1 |
PPP1R26 antisense RNA 1 |
2832 |
0.17 |
chr10_24740047_24740337 | 0.42 |
KIAA1217 |
KIAA1217 |
1830 |
0.43 |
chr3_87034608_87034769 | 0.42 |
VGLL3 |
vestigial like 3 (Drosophila) |
5164 |
0.35 |
chr11_96040354_96040983 | 0.42 |
ENSG00000266192 |
. |
33934 |
0.17 |
chr21_40293202_40293353 | 0.42 |
ENSG00000272015 |
. |
26568 |
0.24 |
chr2_200604849_200605000 | 0.42 |
FTCDNL1 |
formiminotransferase cyclodeaminase N-terminal like |
110672 |
0.07 |
chr9_4144735_4144971 | 0.42 |
GLIS3 |
GLIS family zinc finger 3 |
340 |
0.93 |
chr6_762027_762197 | 0.42 |
EXOC2 |
exocyst complex component 2 |
68995 |
0.13 |
chr2_190244069_190244254 | 0.41 |
WDR75 |
WD repeat domain 75 |
61998 |
0.12 |
chr14_96722602_96722753 | 0.41 |
BDKRB1 |
bradykinin receptor B1 |
130 |
0.94 |
chr5_52327345_52327496 | 0.41 |
CTD-2175A23.1 |
|
41312 |
0.14 |
chr21_31599857_31600016 | 0.41 |
CLDN8 |
claudin 8 |
11545 |
0.17 |
chr4_23891941_23892219 | 0.41 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
380 |
0.92 |
chr5_155305875_155306026 | 0.41 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
8596 |
0.28 |
chr17_13498641_13498792 | 0.41 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
6528 |
0.28 |
chr1_161992740_161992891 | 0.41 |
OLFML2B |
olfactomedin-like 2B |
615 |
0.79 |
chr4_148944622_148945028 | 0.41 |
RP11-76G10.1 |
|
122797 |
0.06 |
chr14_66602242_66602393 | 0.41 |
ENSG00000200860 |
. |
42036 |
0.2 |
chr4_187643852_187644133 | 0.41 |
FAT1 |
FAT atypical cadherin 1 |
1017 |
0.68 |
chr7_134577069_134577242 | 0.41 |
CALD1 |
caldesmon 1 |
794 |
0.75 |
chr4_111166800_111166966 | 0.41 |
ENSG00000212160 |
. |
32458 |
0.19 |
chr5_54281245_54281752 | 0.41 |
ESM1 |
endothelial cell-specific molecule 1 |
7 |
0.97 |
chr18_57332365_57332516 | 0.41 |
CCBE1 |
collagen and calcium binding EGF domains 1 |
954 |
0.57 |
chr18_55889348_55889572 | 0.41 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
657 |
0.77 |
chr12_78334342_78334902 | 0.40 |
NAV3 |
neuron navigator 3 |
25434 |
0.27 |
chr2_36585229_36585663 | 0.40 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
1832 |
0.5 |
chr7_19733441_19733592 | 0.40 |
ENSG00000265932 |
. |
11543 |
0.19 |
chr18_46520644_46520795 | 0.40 |
RP11-15F12.1 |
|
29354 |
0.17 |
chr4_187646786_187647042 | 0.40 |
FAT1 |
FAT atypical cadherin 1 |
962 |
0.7 |
chr12_91570586_91570804 | 0.40 |
DCN |
decorin |
1634 |
0.5 |
chr12_124774068_124774247 | 0.40 |
FAM101A |
family with sequence similarity 101, member A |
447 |
0.88 |
chr2_230309916_230310155 | 0.40 |
ENSG00000238782 |
. |
160919 |
0.04 |
chr6_155375799_155376279 | 0.40 |
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
35384 |
0.21 |
chr7_95704908_95705546 | 0.40 |
ENSG00000208025 |
. |
143841 |
0.04 |
chr12_53044554_53044825 | 0.40 |
KRT2 |
keratin 2 |
1259 |
0.32 |
chr6_126139268_126139437 | 0.40 |
NCOA7-AS1 |
NCOA7 antisense RNA 1 |
652 |
0.69 |
chr8_119120675_119121215 | 0.40 |
EXT1 |
exostosin glycosyltransferase 1 |
1708 |
0.54 |
chr2_202901632_202901854 | 0.39 |
FZD7 |
frizzled family receptor 7 |
2433 |
0.27 |
chr8_42012956_42013246 | 0.39 |
AP3M2 |
adaptor-related protein complex 3, mu 2 subunit |
967 |
0.5 |
chr2_145212843_145212994 | 0.39 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
24781 |
0.24 |
chr11_101984206_101984357 | 0.39 |
YAP1 |
Yes-associated protein 1 |
1036 |
0.49 |
chrX_99890951_99891409 | 0.39 |
TSPAN6 |
tetraspanin 6 |
623 |
0.71 |
chr12_76242388_76242595 | 0.39 |
ENSG00000243420 |
. |
109419 |
0.06 |
chr2_176995490_176995715 | 0.39 |
HOXD8 |
homeobox D8 |
517 |
0.55 |
chr8_87188863_87189124 | 0.39 |
CTD-3118D11.3 |
|
3654 |
0.25 |
chr2_236574591_236575244 | 0.39 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
3331 |
0.35 |
chr4_140808325_140808521 | 0.39 |
MAML3 |
mastermind-like 3 (Drosophila) |
2783 |
0.37 |
chr2_25142056_25142863 | 0.39 |
ADCY3 |
adenylate cyclase 3 |
78 |
0.97 |
chr2_225277050_225277243 | 0.39 |
FAM124B |
family with sequence similarity 124B |
10344 |
0.29 |
chr17_807460_807764 | 0.39 |
RP11-676J12.7 |
Uncharacterized protein |
5260 |
0.18 |
chr7_1407040_1407331 | 0.39 |
MICALL2 |
MICAL-like 2 |
91777 |
0.06 |
chr7_113722711_113723554 | 0.39 |
FOXP2 |
forkhead box P2 |
3483 |
0.3 |
chr13_73438708_73438950 | 0.39 |
ENSG00000220981 |
. |
13603 |
0.19 |
chr11_121967218_121967559 | 0.38 |
ENSG00000207971 |
. |
3164 |
0.21 |
chr2_230451733_230451944 | 0.38 |
ENSG00000238782 |
. |
19116 |
0.27 |
chr21_36256728_36257172 | 0.38 |
RUNX1 |
runt-related transcription factor 1 |
2530 |
0.42 |
chr2_134325837_134326056 | 0.38 |
NCKAP5 |
NCK-associated protein 5 |
85 |
0.98 |
chr10_100069089_100069304 | 0.38 |
LOXL4 |
lysyl oxidase-like 4 |
41189 |
0.15 |
chr6_56707311_56707814 | 0.38 |
DST |
dystonin |
381 |
0.81 |
chr3_136677445_136677648 | 0.38 |
IL20RB |
interleukin 20 receptor beta |
695 |
0.7 |
chr5_9782917_9783068 | 0.38 |
ENSG00000222054 |
. |
21973 |
0.24 |
chr15_99789344_99789838 | 0.38 |
TTC23 |
tetratricopeptide repeat domain 23 |
145 |
0.94 |
chr9_14203547_14203816 | 0.38 |
NFIB |
nuclear factor I/B |
22884 |
0.27 |
chr6_83073110_83073416 | 0.38 |
TPBG |
trophoblast glycoprotein |
85 |
0.98 |
chr4_188524057_188524208 | 0.38 |
ZFP42 |
ZFP42 zinc finger protein |
392793 |
0.01 |
chr15_25638050_25638201 | 0.38 |
UBE3A |
ubiquitin protein ligase E3A |
12528 |
0.11 |
chr18_12315444_12315629 | 0.37 |
TUBB6 |
tubulin, beta 6 class V |
4570 |
0.2 |
chr10_6780355_6780830 | 0.37 |
PRKCQ |
protein kinase C, theta |
158329 |
0.04 |
chr8_30242727_30243445 | 0.37 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
169 |
0.73 |
chr14_51242372_51242693 | 0.37 |
NIN |
ninein (GSK3B interacting protein) |
9019 |
0.17 |
chr5_98112819_98113202 | 0.37 |
RGMB |
repulsive guidance molecule family member b |
3671 |
0.26 |
chr10_32236820_32237004 | 0.37 |
ARHGAP12 |
Rho GTPase activating protein 12 |
19170 |
0.22 |
chr6_69346067_69346218 | 0.37 |
BAI3 |
brain-specific angiogenesis inhibitor 3 |
883 |
0.52 |
chr16_56640770_56640921 | 0.37 |
MT2A |
metallothionein 2A |
1266 |
0.24 |
chr2_199480864_199481015 | 0.37 |
ENSG00000252511 |
. |
49486 |
0.2 |
chr10_88730141_88731006 | 0.37 |
RP11-96C23.15 |
|
10 |
0.87 |
chr4_27219934_27220157 | 0.37 |
ENSG00000222206 |
. |
5004 |
0.36 |
chr8_98102647_98102881 | 0.37 |
KB-1958F4.2 |
|
42843 |
0.16 |
chr2_189840807_189841050 | 0.37 |
COL3A1 |
collagen, type III, alpha 1 |
1829 |
0.32 |
chr1_9515825_9515976 | 0.37 |
ENSG00000252956 |
. |
18063 |
0.22 |
chr3_42094512_42094663 | 0.37 |
TRAK1 |
trafficking protein, kinesin binding 1 |
37975 |
0.19 |
chr8_126667981_126668167 | 0.37 |
ENSG00000266452 |
. |
211267 |
0.02 |
chr16_23144460_23144740 | 0.36 |
USP31 |
ubiquitin specific peptidase 31 |
15991 |
0.22 |
chr6_8433732_8434221 | 0.36 |
SLC35B3 |
solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 |
1740 |
0.54 |
chr4_20253090_20253375 | 0.36 |
SLIT2 |
slit homolog 2 (Drosophila) |
1651 |
0.55 |
chr3_64338126_64338405 | 0.36 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
84610 |
0.09 |
chr8_13369656_13370025 | 0.36 |
DLC1 |
deleted in liver cancer 1 |
2434 |
0.32 |
chr13_93897151_93897349 | 0.36 |
GPC6 |
glypican 6 |
18155 |
0.29 |
chr6_90928649_90929126 | 0.36 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
77574 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 0.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 1.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.3 | 1.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.8 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 0.8 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.5 | GO:0072338 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.4 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.6 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.6 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.2 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.5 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 1.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.2 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.1 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.2 | GO:0060391 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.1 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.0 | 0.7 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.0 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.5 | GO:0090280 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.7 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.0 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.0 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.5 | GO:0060740 | prostate gland epithelium morphogenesis(GO:0060740) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.0 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.0 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0061364 | regulation of negative chemotaxis(GO:0050923) apoptotic process involved in luteolysis(GO:0061364) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0044319 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.2 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0042424 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.3 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 3.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.0 | GO:0090192 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) regulation of glomerulus development(GO:0090192) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.6 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.1 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.0 | GO:0034114 | heterotypic cell-cell adhesion(GO:0034113) regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.0 | 0.0 | GO:0072071 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:1901890 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0045117 | azole transport(GO:0045117) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.3 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.2 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.3 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.4 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.0 | 0.0 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.0 | 0.2 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.0 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.0 | GO:0042816 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.0 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0034243 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.5 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.2 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.2 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
0.0 | 0.0 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0010171 | body morphogenesis(GO:0010171) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.3 | GO:0042698 | ovulation cycle(GO:0042698) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.6 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 4.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 1.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.9 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 1.3 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.4 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 1.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.7 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.5 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.2 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 1.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 4.8 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 2.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |